Novel Resorcinol Dibenzyl Ether-Based PD-L1 Inhibitors Modulate Lipid Metabolism for Enhanced Tumor Immunotherapy
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-03-27 11:40:31 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1021/acs.jmedchem.5c02527
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c02527
其他信息:
出版社: American Chemical Society (ACS)
作者: Zichao Yang; Ziqing Liu; Jiayi Zhou; Pengfei Song; Abdullah Mohsan Nasser Saleh; Jianwei Xu; Xixiang Yang; Yangcheng Ai; Yichang Ren; Zhijie Wang; Jianjun Chen
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c02527

